The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J07 | Vaccines | |
| 3 | J07B | Viral vaccines | |
| 4 | J07BX | Other viral vaccines |
| Code | Title | |
|---|---|---|
| J07BX01 | ||
| J07BX02 | ||
| J07BX03 | ||
| J07BX04 | ||
| J07BX05 | ||
| J07BX06 |
| Active Ingredient | Description | |
|---|---|---|
| Dengue vaccine |
|
|
| Ebola vaccine |
Ebola vaccine consists of a live, attenuated recombinant vesicular stomatitis virus-based vector expressing the envelope glycoprotein gene of Zaire Ebola virus (rVSV∆G-ZEBOV-GP). Immunisation of subjects with the vaccine results in an immune response and protection from Zaire Ebola Virus Disease (EVD). |
|
| RSV glycoprotein F antigen |
RSV glycoprotein F antigen is designed to enhance antigen-specific cellular immune response and neutralizing antibodies response in individuals with pre-existing immunity against RSV. The adjuvant AS01E facilitates the recruitment and activation of antigen presenting cells carrying vaccine-derived antigens in the draining lymph node, which in turn leads to the generation of RSVPreF3-specific CD4+ T cells. |
|
| Smallpox, live attenuated |
Smallpox vaccine is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ABRYSVO Powder and solvent for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ACAM2000 Powder for solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| AREXVY Powder for suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ERVEBO Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| IMVAMUNE Suspension for injection | Health Products and Food Branch (CA) | MPI, CA: SPM | |
| IMVANEX Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| JYNNEOS Suspension for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| MVABEA Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| QDENGA Powder and solvent for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
